ICICI Prudential Life Insurance Company Ltd (ICICIPRULI) Q1 FY27 Results Analysis: PAT Jumps 27.8%, VNB Margin Expands 220 bps

CompoundingAI Research Updated July 15, 2026 2 min read
Positive

ICICI Prudential Life Insurance Company Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 10,251.00 Cr (+14.50% YoY) and PAT growth of +27.80% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 15, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 10,251.00 Cr (+14.50% YoY)
PAT (Q1)Rs. 386.18 Cr (+27.80% YoY)
EPS (Q1)Rs. 2.66 (+27.30% YoY)
Market capRs. 74,461.96 Cr
CMPRs. 513.25

Quarter Snapshot

The company delivered strong Q1 with VNB margin expanding 220 bps and PAT growing 27.8% YoY. Retail protection APE surged 60.4% driven by GST reforms. However, persistency continues to decline and cost ratio increased due to product mix shift. The promoter reclassification adds uncertainty.

Key Investment Insights

Key Positives

  • VNB margin expanded 220 bps YoY to 26.7%, driven by protection mix shift.
  • PAT grew 27.8% YoY to Rs.386.18 cr, with VNB growth of 24.9%.
  • Retail protection APE surged 60.4% YoY, third consecutive quarter of >40% growth.
  • Total expenses grew 8.9% YoY, well below premium growth of 14.5%, indicating operating leverage.
  • Solvency ratio remains strong at 225.4%, well above regulatory minimum of 150%.

Risk Factors

  • 13-month persistency declined to 84.0% from 86.0% a year ago, continuing a downward trend.
  • Total cost-to-premium ratio increased 60 bps to 21.8% due to higher share of protection business.
  • GST input tax credit unavailability acknowledged as a headwind, though partially offset.
  • Promoter reclassification and name change application pending regulatory approval, creating uncertainty.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now